[Evaluation of antihymenolepidose activity of the compound MST-04].
Mikhaĭlitsyn
F S
FS
Trusov
S N
SN
Sevbo
D P
DP
Gitsu
G A
GA
Malakhova
A Iu
AIu
D000284:Administration, Oral; D000818:Animals; D000923:Anticestodal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001549:Benzamides / Q000008:administration & dosage / Q000627:therapeutic use*; D001969:Bromobenzenes / Q000008:administration & dosage / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D006925:Hymenolepiasis / Q000188:drug therapy*; D048189:Hymenolepis nana / Q000187:drug effects*; D051379:Mice
D000923:Anticestodal Agents; D001549:Benzamides; D001969:Bromobenzenes; C545577:MST-04 compound